论文信息 - First-in-human, first-in-class phase 1 study of a novel oral multi-AGC kinase inhibitor AT13148 in patients (pts) with advanced solid tumors. - 字舞流文

First-in-human, first-in-class phase 1 study of a novel oral multi-AGC kinase inhibitor AT13148 in patients (pts) with advanced solid tumors.

Zoe Backholer | Rajiv Kumar | U. Banerji | M. Garrett | T. Yap | R. Ruddle | F. Raynaud | J. Mateo | K. Swales | Alan D. Smith | K. Khan | C. Tran | S. Decordova | Satyanarayana Seeramreddi | R. McLeod | Paul Jones